Adjuvant ultra-hypofractionated radiotherapy up-front to third-generation adjuvant chemotherapy for breast cancer: A retrospective propensity score matched control group study
European Journal of Cancer · 2026-03 · 237 · 116420
DOI: 10.1016/j.ejca.2026.116420 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-03. Verfasst von G. Lazzari und 6 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Lazzari, G., Benevento, I., D'Andrea, B., Bianculli, A., Tucciariello, R., Metallo, V., & Montagna, A. (2026). Adjuvant ultra-hypofractionated radiotherapy up-front to third-generation adjuvant chemotherapy for breast cancer: A retrospective propensity score matched control group study. European Journal of Cancer, 237, 116420. https://doi.org/10.1016/j.ejca.2026.116420
Vancouver
Lazzari G, Benevento I, D'Andrea B, Bianculli A, Tucciariello R, Metallo V, et al. Adjuvant ultra-hypofractionated radiotherapy up-front to third-generation adjuvant chemotherapy for breast cancer: A retrospective propensity score matched control group study. European Journal of Cancer. 2026;237:116420. doi:10.1016/j.ejca.2026.116420
BibTeX
@article{Lazzari2026,
author = {Lazzari, G. and Benevento, I. and D'Andrea, B. and Bianculli, A. and Tucciariello, R. and Metallo, V. and Montagna, A.},
title = {Adjuvant ultra-hypofractionated radiotherapy up-front to third-generation adjuvant chemotherapy for breast cancer: A retrospective propensity score matched control group study},
journal = {European Journal of Cancer},
year = {2026},
volume = {237},
pages = {116420},
doi = {10.1016/j.ejca.2026.116420}
}
EUVIMED